On September 12, Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, will co-chair “Do devices really help the person with diabetes?”, a symposium at the European Association for the Study of Diabetes (EASD) annual meeting in Madrid, Spain. Dr. Kowalski will be joined by Dr. Tadej Battelino, Consultant and Head of the Department of Pediatric and Adolescent Endocrinology at UMC Ljubljana, who will also chair the event. Breakthrough T1D Chief Medical Officer Dr. Thomas Danne will also present.
The following researchers will share insights during the symposium:
Dr. Lutz Heinemann– Connected insulin pens: What are the benefits?
Dr. Mark Evans– What risks to foresee with connected medical devices in diabetes?
Dr. Thomas Danne– Automated insulin delivery technologies: What is there on the horizon?
What: Breakthrough T1D CEO co-chairs symposium on how devices help people with diabetes
Who: Breakthrough T1D CEO, Dr. Aaron J. Kowalski, Dr. Lutz Heinemann, Dr. Mark Evans, Breakthrough T1D Chief Medical Officer, Dr. Thomas Danne
When: Thursday, September 12, 2024, 9-10:30 a.m. CEST
Where: Sofia Hall at the EASD Annual Meeting, IFEMA Convention Center – Feria de Madrid, Avda. del Partenón, 5, 28042 Madrid, Spain
###
